Enabling technologies
Polymers are rapidly developing towards smart functional materials that enable the development of advanced biomedical and pharmaceutical applications. They offer numerous opportunities for breakthrough technologies and innovative products. PolyVation aims to seize these opportunities for the benefit of clients and patients. To capitalize on the possibilities offered by functional polymers, PolyVation is proactively developing novel material technologies and (qualified) manufacturing capabilities that create new product opportunities for our clients.
Specific unique polymer technologies and/or expertise:
- Orthoester (co)polymers (absorbable)
- Oxazoline (co)polymers (absorbable)
- Ester/ether triblock copolymers (absorbable)
- Ester/etherester multi-block (co)polymers (absorbable)
- Hyaluronic acid / Gelatin / Dextran derivates (absorbable)
- Urethane (co)polymers (absorbable and biostable)
- Ester (co)polymers (absorbable and biostable)
- Vinyl pyrrolidone (co)polymers (biostable)
- Acrylate (co)polymers (biostable)
These polymer technologies aim at (not limited):
- Injectable polymer devices
- Functional binders for bone growth promoting putties
- Controlled release depots & vehicles
- Tissue engineering scaffolds & constructs
- Medical device implants
- Lubricious surfaces/coatings
- Prolonged desinfecting skin care
- Adding anti-microbial functionality to devices